Is Found a Good Fit for No Membership Fee? Plans and Costs Examined

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found charges no separate membership fee—clinician access, the Found app, 24/7 care team support, and AI health companion are included in medication cost. PlexusDx follows the same all-in-one pricing model. Both programs bundle clinical and support services into a single monthly charge, so the "no membership fee" criterion does not distinguish them. The meaningful comparison becomes cash medication cost, insurance coverage, format options, and included features. Found offers insurance billing (starting at $199/month for monthly plans, $99/month for 12-month insurance plans) and an integrated app-based coaching platform. PlexusDx offers lower month-to-month cash rates ($189 versus $289 for semaglutide injection), a wider medication menu including oral and microdose formulations, and optional DNA testing for medication response. If you're seeking zero membership fees, both programs deliver; the decision rests on whether insurance coverage and bundled digital support matter more than cash affordability and format choice.

At-a-glance comparison: Found versus PlexusDx

Sources: Found pricing page (accessed 2026-09-04), PlexusDx comparison page and product pages (accessed 2026-07-20 and 2026-07-23). Month-to-month rates shown; see Methodology for annual cost calculations.

Normalized 12-month costs: like-for-like and prepaid options

Because Found bills medication every four weeks (13 charges per year) and PlexusDx bills monthly (12 charges per year), total annual outlay differs even when per-period prices look close. The table below converts both to calendar-year cost, using standard ongoing rates and prepaid totals only captured from each provider's public pages.

All figures are our calculation from standard ongoing rates and prepaid totals only, verified at the dates shown. Found's 48-week billing cycle requires 1.0833 cycles to cover 52 weeks; we multiply the stated 12-month-total by that factor. PlexusDx does not offer a 12-month plan; Found does not offer a 6-month plan. Insurance-track pricing ($99–$199/month at Found, depending on plan length and coverage) is excluded because copay and coverage details vary by patient.

Decision factors: what Found includes and where PlexusDx differs

Found's strengths

• Insurance billing: Found accepts insurance from many major carriers (in-network clinicians for 1 in 3 Americans, per the provider's site). Monthly insurance plans start at $199/month; 12-month insurance plans start at $99/month. Copays may apply, and final cost depends on medication and coverage. If your plan covers GLP-1 weight management and you prefer predictable insurance-based billing, Found offers that pathway.
• Integrated app and coaching: All Found plans include 24/7 access to a care team, personalized habit guidance, Aimee (an AI health companion), and a member community. The app centralizes medication tracking, clinician messaging, and behavioral support in one interface.
• Long-term prepaid savings: Found's 12-month prepaid cash option brings semaglutide to $169/month and tirzepatide to $239/month (each billed every 48 weeks). Over a calendar year that annualizes to $2,197 semaglutide and $3,107 tirzepatide (our calculation). PlexusDx does not offer a 12-month tier, so this rate has no direct comparator.
• Flexible plan switching: Found permits switching between monthly and prepaid tiers at any time by contacting support.
• Refund assurance: Full refund if you are not clinically eligible.

PlexusDx's strengths

• Lower month-to-month cash rates: PlexusDx charges $189/month for semaglutide injection and $289/month for tirzepatide injection on a calendar-month (12-charge-per-year) schedule. Over 12 months that totals $2,268 semaglutide and $3,468 tirzepatide—$1,489 and $1,199 less than Found's month-to-month cash rates, respectively (our calculation).
• Oral and microdose formats: PlexusDx offers oral capsule versions of both compounds (semaglutide $289/month, tirzepatide $349/month month-to-month) and a microdose semaglutide injection at $129/month—options not available through Found's cash program.
• Optional DNA testing for medication response: A $298 standalone test (or $99 for program members) screens for genetic variants that may influence GLP-1 response. The test does not select or predict a medication—your provider decides—but some patients value the data.
• Free Doctor of Pharmacy check-in: Included at no extra charge for medication-interaction and adherence guidance.
• Six-month prepaid rates: PlexusDx's longest commitment tier brings semaglutide to $149/month ($1,788/year) and tirzepatide to $249/month ($2,988/year). Found does not offer a 6-month option.

Shared features and limitations

• Both programs charge zero separate membership fees; all clinician access and support features are included in the medication price.
• Both use compounded medications sourced from licensed U.S. pharmacies (Found works with 503A facilities; PlexusDx does the same).
• Both are HSA/FSA eligible for medication cost (PlexusDx's genetic test is not).
• Neither program provides branded GLP-1 medications in their core compounded cash tracks (Found separately lists branded options like Wegovy and Zepbound, but pricing is not disclosed on the main compounding page).

Choose Found if…

• You have insurance coverage for weight-management medication and prefer predictable monthly or annual insurance billing over cash pay.
• You value an integrated app platform with 24/7 clinician messaging, AI-driven habit tracking, and a built-in community.
• You are comfortable committing to 12 months upfront and want the lowest available cash rate Found offers ($169 semaglutide, $239 tirzepatide per month-total, billed every 48 weeks).
• You want the assurance of a full refund if you are not clinically eligible.

Choose PlexusDx if…

• You pay cash and want the lowest month-to-month rate—$189/mo month-to-month for semaglutide injection or $289/mo month-to-month for tirzepatide injection—with flexibility to cancel anytime without forfeiting prepaid funds.
• You prefer oral medication or want to explore a microdose maintenance option after initial titration.
• You are interested in DNA data for medication response to inform (but not dictate) treatment decisions alongside your provider.
• You value a streamlined service model that includes a PharmD check-in but does not bundle app-based coaching or community features.
• You want to lock in a six-month rate ($149 semaglutide, $249 tirzepatide per month) for a balance of commitment and savings.

Methodology and freshness

We captured Found's month-to-month and prepaid cash pricing from their public pricing page on 2026-09-04 and cross-verified month-to-month rates from a PlexusDx comparison page accessed 2026-07-20. PlexusDx rates were confirmed from product pages accessed 2026-07-20 and 2026-07-23. All prices reflect standard ongoing rates and prepaid totals only, verified at the dates shown. Insurance ranges reflect published minimums; actual patient cost depends on coverage and copays.

Twelve-month cost calculations are our work: we multiplied Found's every-4-weeks rate by 13 charges and PlexusDx's calendar-month rate by 12 charges. Found's 48-week prepaid cycle yields 1.0833 cycles per 52-week year; we multiplied the stated 12-month-total by that factor to show true annual spend. PlexusDx's six-month rate was multiplied by 12 to show the annualized cost of staying on that tier. All figures derive from standard ongoing rates and prepaid totals only.

All compounded-medication regulatory disclosures appear at the end of this article.

Frequently Asked Questions

Does Found charge a membership fee separate from medication cost?

No. Found includes clinician access, the Found app, 24/7 care team support, AI health companion (Aimee), and community features in the medication price. There is no line-item membership or program fee.

How does PlexusDx's pricing model work without a membership fee?

PlexusDx bundles a free Doctor of Pharmacy check-in into each medication subscription. Optional DNA testing for medication response ($99 for members) is separate. Medication cost covers prescribing, compounding, and shipping—no recurring membership charge.

Can I use insurance with PlexusDx?

No. PlexusDx operates on a cash-pay model only. Found accepts insurance from many carriers; monthly insurance plans start at $199/month, and 12-month insurance plans start at $99/month, though copays may apply and final cost varies by medication and coverage.

Why is Found's month-to-month rate billed 13 times per year?

Found bills every four weeks, which over 52 weeks yields 13 billing cycles annually. PlexusDx bills on a calendar-month schedule (12 times per year). This difference affects total annual outlay even when per-period rates appear similar.

Which provider offers the lowest cash price for semaglutide with no long-term commitment?

PlexusDx month-to-month semaglutide injection is $189 per calendar month ($2,268/year), compared to Found's $289 every four weeks ($3,757/year). That represents a $1,489 annual difference (our calculation) for flexible, cancel-anytime access.

Sources

• PlexusDx Found comparison page, accessed 2026-07-20
• Found pricing page (joinFound.com), accessed 2026-09-04
• PlexusDx GLP-1 alternatives grid, accessed 2026-07-23
• PlexusDx product pages (semaglutide injection, tirzepatide injection, oral formulations, microdose), accessed 2026-07-20 and 2026-07-23

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.